AGAli Gungor

Ali Gungor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Gungor has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Flunarizine and Lutein on Atezolizumab-Associated Ovarian Alterations in Rats

    by Ummugulsum Esenkaya, Esra Tuba Sezgin, Sevinc Haciyeva, Bahadir Suleyman, Mustafa Ozkaraca, Ali Gungor, Taha Abdulkadir Coban, Halis Suleyman

    Immune checkpoint inhibitors (ICIs), including atezolizumab, enhance antitumor immune responses by interfering with inhibitory immune checkpoint signaling. Atezolizumab targets programmed death-ligand 1 (PD-L1), thereby disrupting its interaction with programmed death-1 (PD-1). Although ICIs have improved cancer treatment outcomes, their potential associations with ovarian alterations remain insufficiently understood. This study aimed to compare ovarian biochemical, hormonal, histopathological, and immunofluorescence outcomes following the co-administration of flunarizine or lutein with atezolizumab in rats. Twenty-four female Wistar rats were randomly assigned to four groups (n = 6 per group): healthy control (HG), atezolizumab (ATZ), flunarizine plus atezolizumab (FUAZ), and lutein plus atezolizumab (LTAZ). Ovarian oxidative stress markers (MDA, tGSH, SOD, and CAT), inflammatory cytokines (TNF-α and IL-1β), serum anti-Müllerian hormone (AMH) and prolactin levels, histopathological alterations, and immunofluorescence intensities of COX-1, COX-2, IL-1β, and IL-6 were evaluated. Compared with HG, the ATZ group exhibited increased MDA, TNF-α, and IL-1β levels and decreased tGSH, SOD, CAT, and serum AMH levels (p < 0.05). Histopathological examination revealed more pronounced follicular degeneration, parenchymal edema, and hyperemia in the ATZ group, whereas these alterations were milder in the FUAZ group and moderate in the LTAZ group. Immunofluorescence analysis demonstrated reduced COX-1 and increased COX-2, IL-1β, and IL-6 intensities in the ATZ group compared with HG. Both co-administration groups showed higher COX-1 and lower COX-2, IL-1β, and IL-6 intensities than the ATZ group. Several biochemical, histopathological, and immunofluorescence outcomes in the FUAZ group were closer to HG values than those in the LTAZ group. Serum prolactin levels differed significantly only between the ATZ and FUAZ groups in pairwise comparisons. Atezolizumab administration was associated with ovarian oxidative, inflammatory, and histopathological alterations. Co-administration of flunarizine or lutein was associated with differences in several evaluated parameters, with more favorable findings observed in the FUAZ group at the selected doses. However, the absence of appropriate antibody controls and adjunct-only groups limits causal attribution and precludes conclusions regarding independent protective efficacy.

  • Open Access

    Correction: Bulut et al. Liv-52 Attenuates Erlotinib-Induced Liver Injury via Modulation of Oxidative Stress, Inflammation, and Apoptosis in Rats. Int. J. Mol. Sci. 2026, 27, 3817

    by Seval Bulut, Durdu Altuner, Bahadir Suleyman, Renad Mammadov, Mustafa Ozkaraca, Ali Gungor, Mehmet Kuzucu, Engin Hendem, Halis Suleyman

    The following reference [47] has been retracted and should be removed from the original publication

  • Open Access

    Modulation of the Liver–Brain Axis by Ondansetron in Thio-Acetamide-Induced Acute Hepatic Encephalopathy

    by Fatih Mehmet Sari, Yasin Bilgin, Betul Cicek, Engin Kurt, Mustafa Ozkaraca, Ali Gungor, Nezahat Kurt, Asli Ozbek Bilgin

    Hepatic encephalopathy (HE) is a severe neurological complication of liver failure characterized by hyperammonemia, oxidative stress, neuroinflammation, and progressive neuronal dysfunction. Ondansetron (OND), a selective 5-hydroxytryptamine-3 (5-HT3) receptor antagonist, has reported anti-inflammatory and neuroactive properties, but its effects in HE remain poorly defined. This study evaluated OND in a thioacetamide (TAA)-induced acute HE model in female Sprague-Dawley rats. Animals were assigned to Control, TAA, OND, TAA+OND (0.5 mg/kg), and TAA+OND (1 mg/kg) groups. Serum and cerebral glutamine, oxidative and antioxidant parameters, histopathological alterations, and TLR2, NF-κB, IL-1β, GFAP, NLRP3, and caspase-1 immunoreactivity were assessed in liver and brain tissues. TAA increased glutamine accumulation, produced tissue injury, altered redox parameters, and increased several inflammation-related markers. OND significantly reduced cerebral glutamine and attenuated selected biochemical, histopathological, and immunohistochemical alterations, with generally more pronounced effects at 0.5 mg/kg. These findings indicate that OND administration is associated with partial modulation of metabolic, oxidative, inflammatory, and structural alterations in TAA-treated rats, warranting further receptor-specific and functional studies to clarify its mechanisms and therapeutic relevance.

  • Open Access

    Protective Impact of Chia Seed Oil on Autophagic and Ferroptotic Cell Death in Methotrexate-Induced Liver and Kidney Damage

    by Ali Güngör, Mustafa Özkaraca, Mansur Seymen Seğmenoğlu, Uğur Çayanoğlu

    Chia seed oil (CSO) essential fatty acids along with various phenolic compounds. Methotrexate (MTX), which targets rapidly dividing cancer cells and immune system cells, is used in various tumor formations but causes undesirable effects on the kidneys, liver, and various organs. In our study, we primarily investigated the effects of chia seed oil on autophagy and ferroptosis in liver and kidney damage. For this purpose, we formed 3 groups with 21 male Balb/c mice. The CONTROL group received nothing except standard feed and water. The MTX group received a single dose of 20 mg/kg methotrexate intraperitoneally on day 1. The MTX-CSO group received a single dose of 20 mg/kg methotrexate intraperitoneally on day 1, along with 4 ml/kg of chia seed oil administered via gavage. Chia seed oil treatment was continued for 7 days. On the 8th day, the mice were euthanized, and liver and kidney tissues were analyzed using histopathological, immunohistochemical, and double immunofluorescence staining methods. In conclusion, the severe histopathological findings observed in the MTX groups were alleviated in the MTX-CSO group. Immunohistochemical and dual immunofluorescence staining results show that while MTX activates autophagy and ferroptosis markers, CSO suppresses them, exhibiting a protective and regulatory effect. Our research is the first original study to investigate the effect of CSO on autophagic and ferroptotic cell death.

  • Insights into the protective role of trigonelline in 5-fluorouracil–induced lung injury: targeting oxidative stress, inflammation, and apoptosis

    by Hamit Uslu, Gözde Atila Uslu, Taha Abdulkadir Çoban, Mahmut Şahin, Ali Güngör, Serpil Aygörmez

  • Open Access

    Liraglutide Attenuates Multiorgan Oxidative, Astroglial, and Mitochondrial Stress Responses in Thioacetamide-Induced Hepatic Encephalopathy

    by Yasin Bilgin, Fatih Mehmet Sari, Betul Cicek, Engin Kurt, Mustafa Ozkaraca, Ali Gungor, Nezahat Kurt, Asli Ozbek Bilgin

    Hepatic encephalopathy (HE) is a complex complication of liver failure involving oxidative stress, astroglial activation, mitochondrial dysfunction, and multiorgan disturbances along the gut–liver–brain axis. This study investigated the therapeutic effects of liraglutide (LIRA) in a thioacetamide (TAA)-induced rat model of HE. Thirty male Sprague–Dawley rats were assigned to control, TAA, and TAA+LIRA 100, 200, or 400 µg/kg groups. HE was induced with TAA (200 mg/kg, intraperitoneally) for three consecutive days, followed by subcutaneous LIRA treatment for 14 days. Serum biochemical parameters, tissue oxidative and inflammatory markers, histopathology, and Nrf2, MFN2, AKT1, mTOR, GFAP, and VEGFA immunoreactivity were evaluated. TAA caused marked hepatic and cerebral structural injury, increased serum and brain glutamine concentrations, disrupted redox homeostasis, elevated MPO activity, and increased cerebral GFAP and multiorgan VEGFA immunoreactivity. LIRA partially improved hepatic and cerebral histopathology, reduced glutamine disturbances, attenuated selected oxidative, nitrosative, and inflammatory alterations, and modulated Nrf2, MFN2, AKT1, mTOR, GFAP, and VEGFA immunoreactivity in a tissue- and dose-specific manner. The 200 µg/kg dose produced the most consistent overall improvement, whereas the 400 µg/kg dose was less favorable for several endpoints. LIRA may therefore alleviate multiorgan stress associated with experimental HE, although further studies are required to confirm functional and mechanistic relevance.

  • Open Access

    Protective Effects of Ranolazine in a Rat Model of Ovarian Ischemia/Reperfusion Injury

    by Mesut Admis, Esra Tuba Sezgin, Zeynep Suleyman, Ozlem Admis, Mustafa Ozkaraca, Ali Gungor, Aydin Aliyev, Halis Suleyman

    Ovarian ischemia/reperfusion (I/R) injury is a major cause of tissue damage following the surgical detorsion of ovarian torsion and is characterized by excessive oxidative stress, inflammation, and progressive cellular injury. Although ranolazine has been reported to exert antioxidant and anti-inflammatory effects in various experimental models, its potential protective effects against ovarian I/R injury have not yet been investigated. This study aimed to evaluate whether pretreatment with ranolazine protects ovarian tissue against experimental I/R injury in rats. Twenty-four female Wistar albino rats were randomly assigned to four groups: a healthy group (HG), sham-operated group (SOG), ovarian ischemia/reperfusion (OIR) group, and ranolazine-treated ovarian ischemia/reperfusion (ROIR) group. Ovarian ischemia was induced by 1 h of torsion followed by 6 h of reperfusion. Ranolazine (50 mg/kg) was administered 1 h before the induction of ischemia as a preventive pretreatment. Oxidative stress markers (MDA, tGSH, SOD, and CAT), pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6), histopathological alterations, and the expression of COX-1, COX-2, IL-1β, and IL-6 were evaluated by double immunofluorescence staining. Ovarian I/R significantly increased MDA and pro-inflammatory cytokine levels while markedly decreasing tGSH levels and SOD and CAT activities (p < 0.001). These biochemical alterations were accompanied by severe follicular degeneration, mononuclear cell infiltration, interstitial edema, decreased COX-1 immunoreactivity, and increased expression of COX-2, IL-1β, and IL-6. Ranolazine treatment significantly attenuated oxidative stress and inflammatory responses, preserved the antioxidant defense system, ameliorated histopathological damage, restored COX-1 immunoreactivity, and inhibited the expression of COX-2, IL-1β, and IL-6. This is the first experimental study evaluating ranolazine in ovarian I/R injury. These findings suggest that preventive pretreatment with ranolazine attenuates experimental ovarian I/R injury through antioxidant and anti-inflammatory mechanisms. Future studies are needed to determine whether similar protective effects can be achieved when ranolazine is administered after ovarian torsion or following surgical detorsion.

  • Open Access

    Effects of ATP and Taxifolin on Atezolizumab-Induced Renal Injury: A Biochemical, Histopathological, and Immunofluorescence Evaluation

    by Adil Furkan Kilic, Esra Tuba Sezgin, Gulbaniz Huseynova, Cengiz Sarigul, Mustafa Ozkaraca, Ali Gungor, Renad Mammadov, Halis Suleyman, Orhan Cimen

    Background: Immune checkpoint inhibitors (ICIs), particularly programmed death-ligand 1 (PD-L1) inhibitors such as atezolizumab, have significantly improved outcomes in cancer therapy. However, these agents may cause immune-related adverse effects, including nephrotoxicity associated with oxidative stress and cellular stress responses. This study aimed to investigate and comparatively evaluate the protective effects of adenosine triphosphate (ATP) and taxifolin against atezolizumab-induced renal tissue injury in rats. Methods: Animals were divided into four groups: healthy (HG), atezolizumab (ATZ), ATP + atezolizumab (ATAZ), and taxifolin + atezolizumab (TXAZ). ATP (4 mg/kg, i.p.) and taxifolin (50 mg/kg, oral) were administered for six days, while atezolizumab (10 mg/kg, i.p.) was given on days 1 and 4. On day 7, renal tissues were collected for biochemical, histopathological, and double immunofluorescence analyses. Results: Atezolizumab significantly increased malondialdehyde (MDA) levels and decreased total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) levels, indicating enhanced oxidative stress and impaired antioxidant defense. These changes were accompanied by tubular degeneration and increased expression of apoptotic markers. Both ATP and taxifolin significantly ameliorated these alterations; however, ATP demonstrated a more pronounced protective effect. Conclusions: In conclusion, ATP and taxifolin attenuated the biochemical, histopathological, and immunofluorescence alterations associated with atezolizumab administration. ATP exhibited a more pronounced protective effect than taxifolin under the conditions of this experimental model. Nevertheless, further experimental studies are required to elucidate the mechanisms underlying these effects.


  • Effect of Chia Seed Oil on Spleen İmmune Cell Markers in Methotrexate-İnduced İmmunosuppression in Mice

    by Ali Güngör, Mustafa Özkaraca, Mansur Seymen Seğmenoğlu, Ali Sefa Mendil

    Chia seed oil (CSO) is a rich source of alpha-linolenic acid (ALA) and various antioxidant compounds, including myricetin, quercetin, kaempferol, and caffeic acid, which are known to exert immunomodulatory effects. Methotrexate (MTX), a commonly used antineoplastic agent, causes immunosuppression. This study aimed to evaluate the immunomodulatory effects of CSO on splenic immune cell populations in a methotrexate-induced immunosuppression model. Twenty-one male Balb/c mice were randomly divided into control, MTX, and MTX+CSO groups. The control group received a standard diet, while the MTX group was administered a single intraperitoneal dose of 20 mg/kg MTX. The MTX+CSO group received a single intraperitoneal dose of 20 mg/kg MTX, followed by 4 mL/kg CSO via oral gavage for 7 days. All animals were euthanized on day 8, and spleen tissues were examined histopathologically and immunohistochemically for CD4+, CD8+, CD20+, and CD68+ cell markers. No significant histopathological alterations were observed in spleen tissues among the groups; however, significant differences were detected in immune cell marker expression. MTX administration reduced CD4+, CD8+, and CD68+ cell populations compared to the control group, whereas CSO treatment significantly restored these levels. Notably, CD4+ cell expression in the MTX+CSO group exceeded that of the control group. Additionally, CD20+ cell expression showed a marked increase following CSO administration. These findings indicate that CSO ameliorates MTX-induced immunosuppression by enhancing splenic T lymphocyte (CD4+, CD8+), B lymphocyte (CD20+), and macrophage (CD68+) populations, suggesting its potential as a natural immunomodulatory agent against chemotherapy-induced immune suppression.

  • Open Access

    ATP and Liv-52 Ameliorate Linezolid-Induced Liver Injury via Modulation of NF-κB/NLRP3 Pathways

    by Serkan Cerrah, Ahmed Ramiz Baykan, Esra Tuba Sezgin, Gulbaniz Huseynova, Elif Karabacak, Serdar Tanas, Emine Kartal Baykan, Murat Gunay, Ali Gungor, Halis Suleyman

    Objective: Linezolid (LZD), an oxazolidinone antibiotic widely used against Gram-positive infections, has been associated with mitochondrial dysfunction and hepatotoxicity, particularly during prolonged use. This study aimed to investigate the protective effects of adenosine triphosphate (ATP) and Liv-52 against LZD-induced liver injury, with a focus on oxidative stress, inflammation, and necroptosis pathways. Methods: Twenty-four male Wistar rats were randomly assigned to four groups: healthy control (HG), LZD-treated (LZDG), Liv-52 + LZD (LVLZ), and ATP + LZD (ATLZ). Liv-52 (50 mg/kg, orally) and ATP (5 mg/kg, intraperitoneally) were administered prior to LZD (125 mg/kg, orally) for 14 days. Results: Following LZD administration, malondialdehyde (MDA) levels markedly increased, indicating oxidative stress, while total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) activities significantly decreased. Histopathological examination revealed pronounced hepatocellular damage accompanied by increased NF-κB, NLRP3, RIPK3, and MLKL expression, indicating activation of inflammatory and necroptotic pathways. Treatment with ATP and Liv-52 significantly ameliorated these biochemical, histopathological, and molecular alterations. Conclusions: Treatment with ATP and Liv-52 significantly attenuated oxidative stress, improved histopathological alterations, and suppressed the expression of inflammatory and necroptotic markers. Notably, ATP exhibited a more pronounced protective effect compared to Liv-52. In conclusion, LZD induces hepatotoxicity through oxidative stress-mediated inflammatory and necroptotic mechanisms, while ATP and Liv-52 confer hepatoprotection, with ATP showing superior efficacy.